CLBTW - Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript
2025-02-13 19:14:26 ET
Cellebrite DI Ltd. (CLBT)
Q4 2024 Earnings Conference Call
February 13, 2025, 08:30 AM ET
Company Participants
Andrew Kramer - IR
Tom Hogan - Interim CEO
Dana Gerner - CFO
Marcus Jewell - CRO
Ronnen Armon - Chief Products and Technology Officer
Conference Call Participants
Shaul Eyal - TD Cowen
Bhavin Shah - Deutsche Bank
Eric Martinuzzi - Lake Street
Charlotte Bedick - JPMorgan
Jeff Rhee - Craig-Hallum
Mike Cikos - Needham
Tomer Zilberman - Bank of America
Louie DiPalma - William Blair
Presentation
Operator
Welcome to the Cellebrite Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions] I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.
Andrew Kramer
Thank you, Jim, and welcome, everybody, to Cellebrite's fourth quarter and full year 2024 financial results call. I'm joined today at our headquarters just outside of Tel Aviv by our primary speakers, Tom Hogan, Cellebrite's Interim CEO; and Dana Gerner, Cellebrite's CFO. Ronnen Armon, our Chief Products and Technology Officer; and Marcus Jewell, our Chief Revenue Officer, will be available during the Q&A. There's a slide presentation that accompanies our prepared remarks. Please advance the slides in the webcast viewer to follow our commentary. We will call out the slide number we're referring to in our remarks. The call is being recorded, and a replay of the recording will be made available on our website shortly after the call, along with the transcript of the event.
Now let's start with Slide number 2. A copy of today's press release and financial statements, including the GAAP to non-GAAP reconciliations, the slide presentation and the quarterly financial tables and supplemental historical financial information for each quarter of the past three years are available on the Investor Relations website at investors.cellebrite.com. Also, unless stated otherwise, our discussion of our fourth quarter and full year 2024 financial metrics as well as the financial metrics provided in our outlook will be done on a non-GAAP basis only, and all historical comparisons are with the comparable periods in 2023.
In addition, please note that statements made during this call that are not statements of historical fact constitute forward-looking statements All forward-looking statements are subject to risks and uncertainties and other factors that could cause matters expressed or implied by those forward-looking statements not to occur. They could also cause actual results to differ materially from historical results and/or from forecasts. Some of these forward-looking statements are discussed under the heading Risk Factors and elsewhere in the company's Annual Report on Form 20-F filed with the SEC on March 21, 2024, and as amended on April 12, 2024. The company does not undertake to update any forward-looking statements to reflect future events or circumstances....
Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript